Christopher Horan, Chief Technology Operations Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 7,002 shares at $9.01 ($63K) on 2026-05-19, disclosed to the SEC on 2026-05-19.
Open-market sale of $63k ARTV by Chief Technology Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.